Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
186,913,555
-
Share change
-
-1,516,865
-
Total reported value
-
$51,164,896,552
-
Put/Call ratio
-
134%
-
Price per share
-
$273.82
-
Number of holders
-
1,096
-
Value change
-
-$488,678,007
-
Number of buys
-
505
-
Number of sells
-
513
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2018
As of 31 Mar 2018,
BIOGEN INC. - COM (BIIB) was held by
1,096 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
186,913,555 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, Clearbridge Investments, LLC, STATE STREET CORP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., PRICE T ROWE ASSOCIATES INC /MD/, and Invesco Ltd..
This page lists
1,097
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.